Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics
Authors
Keywords
-
Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2018-04-26
DOI
10.1080/07391102.2018.1470035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs
- (2017) Mohammed A. Khedr et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Unknown
- (2015) JOURNAL OF INTERNAL MEDICINE
- Delamanid for Extensively Drug-Resistant Tuberculosis
- (2015) Rajesh Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval of Bedaquiline — The Benefit–Risk Balance for Drug-Resistant Tuberculosis
- (2014) Edward Cox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphism in two biologically active dihydropyrimidinium hydrochloride derivatives: quantitative inputs towards the energetics associated with crystal packing
- (2014) Piyush Panini et al. Acta Crystallographica Section B-Structural Science Crystal Engineering and Materials
- {2-[(1,3-Benzothiazol-2-yl)methoxy]-5-chlorophenyl}(4-chlorophenyl)methanone
- (2013) K. N. Venugopala et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- {2-[(1,3-Benzothiazol-2-yl)methoxy]-5-bromophenyl}(phenyl)methanone
- (2013) K. N. Venugopala et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- {2-[(1,3-Benzothiazol-2-yl)methoxy]-5-fluorophenyl}(4-chlorophenyl)methanone
- (2013) K. N. Venugopala et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- Synthesis and antimosquito properties of 2,6-substituted benzo[d]thiazole and 2,4-substituted benzo[d]thiazole analogues against Anopheles arabiensis
- (2013) Katharigatta Narayanaswamy Venugopala et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- (2-(Benzo[d]thiazol-2yl-methoxy)-5-chlorophenyl)(phenyl)methanone
- (2012) K. N. Venugopala et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- [2-(1,3-Benzothiazol-2-ylmethoxy)-5-bromophenyl](4-chlorophenyl)methanone
- (2012) Susanta K. Nayak et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- Synthesis and Antitubercular Activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium Chlorides
- (2012) Venugopala K. Narayanaswamy et al. Chemical Biology & Drug Design
- Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
- (2012) María Eugenia Jiménez-Corona et al. THORAX
- Total synthesis of a depsidomycin analogue by convergent solid-phase peptide synthesis and macrolactonization strategy for antitubercular activity
- (2011) Venugopala K. Narayanaswamy et al. JOURNAL OF PEPTIDE SCIENCE
- Mechanism-based Inactivation by Aromatization of the Transaminase BioA Involved in Biotin Biosynthesis inMycobaterium tuberculosis
- (2011) Ce Shi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1
- (2008) Susan M. Westaway et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mercury CSD 2.0– new features for the visualization and investigation of crystal structures
- (2008) Clare F. Macrae et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now